Achmea Investment Management B.V. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Achmea Investment Management B.V. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$258,000
-48.8%
14,1530.0%0.01%
-47.4%
Q2 2019$504,000
+5.9%
14,1530.0%0.02%
-5.0%
Q1 2019$476,000
+2.4%
14,1530.0%0.02%
-4.8%
Q4 2018$465,000
-46.1%
14,1530.0%0.02%
-36.4%
Q3 2018$862,000
+24.7%
14,1530.0%0.03%
+37.5%
Q2 2018$691,00014,1530.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders